Since 2006, we have aggressively managed patients with idiopathic pulmonary arterial hypertension (iPAH) awaiting lung transplantation (LT) with admission to hospital and implementation of high flow O2, mechanical ventilation, inotropic support and use of Novalung as necessary. In this study, we analyzed the impact of this strategy on pre- and post-LT outcomes by comparing the current results to the previous era.

To review the outcomes of lung transplant in recipients >65 years (yr) of age at a single transplant centre.

Coronary artery disease (CAD) is not an uncommon finding in otherwise acceptable lung transplant (LT) candidates. Coronary interventions either pre-transplant or concurrent with LT have been performed at our centre and other centers hoping to minimize post-operative morbidity and improve long-term outcomes. We sought to evaluate the outcome of patients who have undergone intervention for CAD prior to or concurrently with LT.

Transplant programs that service large geographic areas are faced with logistical challenges to meet the needs of remote patients. To improve access, our lung transplant (LTx) program partnered with our Telehealth (TH) Program and remote caregivers to use live videoconferencing. Here, we describe our initial experience with TH including location of patients, types of visits, attending support persons and outcomes of TH consultations.

Purpose: To assess the burdens experienced by caregivers of candidates waiting for lung transplant and, to determine if caregivers who relocated experienced greater burden than caregivers who did not need to relocate.